RPG Life Sciences eyeing overseas tie-ups to push its products

22 Oct 2010 Evaluate

With a view to push its bulk drugs and immuno-suppressant products overseas, RPG Life Sciences is eyeing marketing and distribution tie-ups with foreign companies.The RPG Group company is eyeing the European market for both its bulk drugs and immuno-suppressants

The company has recently inked a co-operation pact with Poland's Polpharma, to develop and manufacture Active Pharmaceutical Ingredients (APIs) and in the management of the supply-chain of selected high-value APIs like clopidogrel bisulphate. The tie-up will help the RPG Group company push its products in Europe. Both the companies will buy products from each other and sell them in their respective strong markets. RPG is in in talks for marketing tie-ups for selling its products in Germany, Greece and Poland and expects some tie-ups to fructify over the next three-months. 

crackcrack

RPG Life Sciences Share Price

1451.95 1.45 (0.10%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.